EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.7.11.23 | Alzheimer Disease |
23566654 |
DNA-dependent protein kinase and DNA repair: relevance to Alzheimer's disease. |
diagnostic usage unassigned |
2 0 |
2.7.11.23 | Alzheimer Disease |
27376156 |
DNA-PK Deficiency in Alzheimer's Disease. |
causal interaction unassigned |
4 0 |
2.7.11.23 | Anemia |
10964778 |
An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation. |
ongoing research unassigned |
3 0 |
2.7.11.23 | Asthma |
25441643 |
DNA-dependent protein kinase inhibition blocks asthma in mice and modulates human endothelial and CD4(+) T-cell function without causing severe combined immunodeficiency. |
causal interaction therapeutic application unassigned |
3 2 0 |
2.7.11.23 | Asthma |
25692509 |
Dendritic cells induce Th2-mediated airway inflammatory responses to house dust mite via DNA-dependent protein kinase. |
causal interaction therapeutic application unassigned |
4 4 0 |
2.7.11.23 | Asthma |
30233855 |
Oxidative damage and DNA damage in lungs of an ovalbumin-induced asthmatic murine model. |
causal interaction therapeutic application unassigned |
4 4 0 |
2.7.11.23 | Astrocytoma |
18952587 |
IGFBP2 is overexpressed by pediatric malignant astrocytomas and induces the repair enzyme DNA-PK. |
causal interaction therapeutic application unassigned |
3 1 0 |
2.7.11.23 | Ataxia |
10341340 |
[Cell cycle regulation after exposure to ionizing radiation] |
causal interaction unassigned |
3 0 |
2.7.11.23 | Ataxia |
10446957 |
Enhanced phosphorylation of p53 serine 18 following DNA damage in DNA-dependent protein kinase catalytic subunit-deficient cells. |
therapeutic application unassigned |
1 0 |
2.7.11.23 | Ataxia |
10473346 |
Replication protein A (RPA): the eukaryotic SSB. |
causal interaction therapeutic application unassigned |
4 1 0 |